Literature DB >> 6326772

Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors.

E Eigenbrodt, S Leib, W Krămer, R R Friis, W Schoner.   

Abstract

The kinetic and structural properties of purified, homogeneous pyruvate kinase type M2 from chicken lung and tumors, including that from Rous sarcoma virus-transformed chicken fibroblasts, have been compared. The "tumor enzyme" is characterized by a low affinity for phosphoenolpyruvate, pronounced serine activation, and strong alanine inhibition as compared to the "lung type". In contrast to the rat lung enzyme, which is not affected by serine, the chicken lung enzyme is slightly activated by serine. The serine metabolites phosphoserine and glycine do not activate the "tumor type M2 pyruvate kinase", but L-alpha-glycerophosphorylcholine and phosphatidylserine do slightly activate at physiological concentrations. Studies with substances structurally related to serine reveal that the hydroxyl group of serine is a prerequisite for the activation and that the amino and carboxyl groups determine the affinity of the "tumor type M2 pyruvate kinase" for serine. Two different fragmentation methods (CNBr-cleavage and V-8 proteolysis) and two different methods for separation of the resulting peptide fragments (polyacrylamide gel isoelectric focussing and SDS-polyacrylamide electrophoresis) indicated a high degree of homology between the type M2 pyruvate kinases from lung and tumors as well the type M1 from muscle. Each type of pyruvate kinase, however, contains one or two unique protein fragments which are characteristic for its type. We have termed those fragments L (lung), M (muscle), and T (tumor).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6326772

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  12 in total

1.  Signaling in control of cell growth and metabolism.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

Review 2.  Pyruvate kinase: Function, regulation and role in cancer.

Authors:  William J Israelsen; Matthew G Vander Heiden
Journal:  Semin Cell Dev Biol       Date:  2015-08-13       Impact factor: 7.727

Review 3.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?

Authors:  Albert M Li; Jiangbin Ye
Journal:  Cancer Lett       Date:  2020-02-04       Impact factor: 8.679

5.  Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation.

Authors:  Jiangbin Ye; Anthony Mancuso; Xuemei Tong; Patrick S Ward; Jing Fan; Joshua D Rabinowitz; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 6.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 7.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

8.  Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation.

Authors:  Jamie A Macpherson; Alina Theisen; Laura Masino; Louise Fets; Paul C Driscoll; Vesela Encheva; Ambrosius P Snijders; Stephen R Martin; Jens Kleinjung; Perdita E Barran; Franca Fraternali; Dimitrios Anastasiou
Journal:  Elife       Date:  2019-07-02       Impact factor: 8.713

9.  Serine is a natural ligand and allosteric activator of pyruvate kinase M2.

Authors:  Barbara Chaneton; Petra Hillmann; Liang Zheng; Agnès C L Martin; Oliver D K Maddocks; Achuthanunni Chokkathukalam; Joseph E Coyle; Andris Jankevics; Finn P Holding; Karen H Vousden; Christian Frezza; Marc O'Reilly; Eyal Gottlieb
Journal:  Nature       Date:  2012-10-14       Impact factor: 49.962

Review 10.  Pyruvate Kinase M2: A Potential Target for Regulating Inflammation.

Authors:  Jose C Alves-Filho; Eva M Pålsson-McDermott
Journal:  Front Immunol       Date:  2016-04-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.